Application | Comment | Organism |
---|---|---|
medicine | potential drug target for malaria chemotherapy | Homo sapiens |
medicine | potential drug target for malaria chemotherapy | Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,1'-sulfanediylbis(2,4-dinitrobenzene) | IC50: 0.004 mM | Homo sapiens | |
1,1'-sulfanediylbis(2,4-dinitrobenzene) | IC50: 0.0005 mM | Plasmodium falciparum | |
1,1'-sulfanediylbis[2-nitro-4-(trifluoromethyl)benzene] | IC50: 0.15 mM | Homo sapiens | |
1,1'-sulfanediylbis[2-nitro-4-(trifluoromethyl)benzene] | IC50: 0.02 mM | Plasmodium falciparum | |
1,3-dinitro-5-(trifluoromethyl)benzene | IC50: 0.2 mM | Homo sapiens | |
1,3-dinitro-5-(trifluoromethyl)benzene | IC50: 0.03 mM | Plasmodium falciparum | |
2-chloro-1,3-dinitro-5-(trifluoromethyl)benzene | IC50: 0.1 mM | Homo sapiens | |
2-chloro-1,3-dinitro-5-(trifluoromethyl)benzene | IC50: 0.008 mM | Plasmodium falciparum | |
4,5-dinitro-1,3-benzodioxole | IC50: 0.08 mM | Homo sapiens | |
4,5-dinitro-1,3-benzodioxole | IC50: 0.01 mM | Plasmodium falciparum | |
4,6-dinitro-2,1,3-benzothiadiazole | IC50: 0.002 mM | Homo sapiens | |
4,6-dinitro-2,1,3-benzothiadiazole | IC50: 0.01 mM | Plasmodium falciparum | |
4-nitro-2,1,3-benzothiadiazole | IC50: 0.05 mM | Homo sapiens | |
4-nitro-2,1,3-benzothiadiazole | IC50: 0.002 mM | Plasmodium falciparum | |
5-nitro-1,3-benzodioxole | IC50: 0.2 mM | Homo sapiens | |
5-nitro-1,3-benzodioxole | 0.1 mM, 10% inhibition | Plasmodium falciparum | |
5-nitro-2,1,3-benzothiadiazole | IC50: 0.09 mM | Homo sapiens | |
5-nitro-2,1,3-benzothiadiazole | IC50: 0.01 mM | Plasmodium falciparum | |
6,7-dinitroquinoxaline | IC50: 0.14 mM | Homo sapiens | |
6,7-dinitroquinoxaline | IC50: 0.002 mM | Plasmodium falciparum | |
6-nitroquinoxaline | IC50: 0.2 mM | Homo sapiens | |
6-nitroquinoxaline | IC50: 0.04 mM | Plasmodium falciparum |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
55000 | - |
2 * 55000 | Homo sapiens |
55000 | - |
2 * 55000 | Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Plasmodium falciparum | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
thioredoxin + NADP+ | - |
Homo sapiens | thioredoxin disulfide + NADPH | - |
? | |
thioredoxin + NADP+ | - |
Plasmodium falciparum | thioredoxin disulfide + NADPH | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | 2 * 55000 | Homo sapiens |
homodimer | 2 * 55000 | Plasmodium falciparum |
Synonyms | Comment | Organism |
---|---|---|
thioredoxin reductase | - |
Homo sapiens |
thioredoxin reductase | - |
Plasmodium falciparum |
TrxR | - |
Homo sapiens |
TrxR | - |
Plasmodium falciparum |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
FAD | - |
Homo sapiens | |
FAD | - |
Plasmodium falciparum |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0005 | - |
IC50: 0.0005 mM | Plasmodium falciparum | 1,1'-sulfanediylbis(2,4-dinitrobenzene) | |
0.002 | - |
IC50: 0.002 mM | Plasmodium falciparum | 4-nitro-2,1,3-benzothiadiazole | |
0.002 | - |
IC50: 0.002 mM | Plasmodium falciparum | 6,7-dinitroquinoxaline | |
0.002 | - |
IC50: 0.002 mM | Homo sapiens | 4,6-dinitro-2,1,3-benzothiadiazole | |
0.004 | - |
IC50: 0.004 mM | Homo sapiens | 1,1'-sulfanediylbis(2,4-dinitrobenzene) | |
0.008 | - |
IC50: 0.008 mM | Plasmodium falciparum | 2-chloro-1,3-dinitro-5-(trifluoromethyl)benzene | |
0.01 | - |
IC50: 0.01 mM | Plasmodium falciparum | 5-nitro-2,1,3-benzothiadiazole | |
0.01 | - |
IC50: 0.01 mM | Plasmodium falciparum | 4,6-dinitro-2,1,3-benzothiadiazole | |
0.01 | - |
IC50: 0.01 mM | Plasmodium falciparum | 4,5-dinitro-1,3-benzodioxole | |
0.02 | - |
IC50: 0.02 mM | Plasmodium falciparum | 1,1'-sulfanediylbis[2-nitro-4-(trifluoromethyl)benzene] | |
0.03 | - |
IC50: 0.03 mM | Plasmodium falciparum | 1,3-dinitro-5-(trifluoromethyl)benzene | |
0.04 | - |
IC50: 0.04 mM | Plasmodium falciparum | 6-nitroquinoxaline | |
0.05 | - |
IC50: 0.05 mM | Homo sapiens | 4-nitro-2,1,3-benzothiadiazole | |
0.08 | - |
IC50: 0.08 mM | Homo sapiens | 4,5-dinitro-1,3-benzodioxole | |
0.09 | - |
IC50: 0.09 mM | Homo sapiens | 5-nitro-2,1,3-benzothiadiazole | |
0.1 | - |
IC50: 0.1 mM | Homo sapiens | 2-chloro-1,3-dinitro-5-(trifluoromethyl)benzene | |
0.14 | - |
IC50: 0.14 mM | Homo sapiens | 6,7-dinitroquinoxaline | |
0.15 | - |
IC50: 0.15 mM | Homo sapiens | 1,1'-sulfanediylbis[2-nitro-4-(trifluoromethyl)benzene] | |
0.2 | - |
IC50: 0.2 mM | Homo sapiens | 1,3-dinitro-5-(trifluoromethyl)benzene | |
0.2 | - |
IC50: 0.2 mM | Homo sapiens | 6-nitroquinoxaline | |
0.2 | - |
IC50: 0.2 mM | Homo sapiens | 5-nitro-1,3-benzodioxole |